Join us as we discuss and provide expert insights into current events impacting our management of pain and substance use disorders. In this episode, host Shravani Durbhakula, MD, MPH, MBA, dives into critical current events and regulatory changes impacting the field of pain medicine and their implications for patient care. She interviews two guests at the forefront of pain medicine, substance use, and addiction: Dr. Antje M. Barreveld, MD, and  Dr. Sudheer Potru, DO, FASA, FASAM.

Dr. Barreveld serves as the Director of Education and Outreach, Co-Founder of Substance Use Services, and the Medical Director of Pain Management Services at Newton-Wellesley Hospital. She also holds a position as an Associate Professor of Anesthesiology at Tufts University School of Medicine and serves on the board of the American Academy of Pain Medicine. Dr. Potru is triple-board certified in anesthesiology, pain medicine, and addiction. He serves as the Director of the Complex Pain Clinic at the Atlanta VA Medical Center and as Assistant Professor at the Department of Anesthesiology at Emory University School of Medicine. 

Tune in to hear the latest on: 

• The FDA's Recent Approval of Over-the-Counter Naloxone: What does this mean for pain medicine providers and their patients? How will it impact the broader opioid crisis and overdose prevention efforts?
• New DEA Requirements for Prescribers of Controlled Substances: We'll unpack these new regulations and how to fulfill them. 
• The Alex Murdaugh Case's Medical Questions: Our guests will provide their expert insights on the complex intersections of pain, substance use, and legality as they emerge in high-profile cases like this one.

Innovative Harm Reduction Approaches, such as the Fentanyl Vaccine: How do these cutting-edge strategies fit into the broader landscape of pain management and addiction treatment?